Cover Image
市場調查報告書

風濕性多發性肌痛症:全球臨床實驗檢討

Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 308261
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
風濕性多發性肌痛症:全球臨床實驗檢討 Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月14日 內容資訊: 英文 130 Pages
簡介

本報告提供風濕性多發性肌痛症相關臨床研究之最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7個國家)的臨床實驗數及實驗對像採用狀況,地區、Phase、階段別進展,有潛力的贊助商,再彙整各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 風濕性多發性肌痛症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,風濕性多發性肌痛症臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:進展狀況別

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Mundipharma International Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • Hospital San Pietro Fatebenefratelli
    • University Hospital, Brest
    • University Hospitals Bristol NHS Trust
    • The Hospital Santa Maria Nuova
    • St. Vincent's University Hospital
    • 琦玉醫科大學
    • Bnai Zion Medical Center
    • Bispebjerg Hospital
    • UMC Utrecht Holding BV

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2242CTIDB

GlobalData's clinical trial report, "Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014" provides data on the Polymyalgia Rheumatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polymyalgia Rheumatica. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polymyalgia Rheumatica. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Polymyalgia Rheumatica
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Polymyalgia Rheumatica
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Polymyalgia Rheumatica Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Mundipharma International Limited
      • Clinical Trial Overview of Mundipharma International Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Hospital San Pietro Fatebenefratelli
      • Clinical Trial Overview of Hospital San Pietro Fatebenefratelli
      • University Hospital, Brest
      • Clinical Trial Overview of University Hospital, Brest
      • University Hospitals Bristol NHS Trust
      • Clinical Trial Overview of University Hospitals Bristol NHS Trust
      • The Hospital Santa Maria Nuova
      • Clinical Trial Overview of The Hospital Santa Maria Nuova
      • St. Vincent's University Hospital
      • Clinical Trial Overview of St. Vincent's University Hospital
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Bnai Zion Medical Center
      • Clinical Trial Overview of Bnai Zion Medical Center
      • Bispebjerg Hospital
      • Clinical Trial Overview of Bispebjerg Hospital
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Region, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Polymyalgia Rheumatica Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital San Pietro Fatebenefratelli, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Bristol NHS Trust, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital Santa Maria Nuova, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Vincent's University Hospital, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Bnai Zion Medical Center, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*

List of Figures

  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Polymyalgia Rheumatica Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top